Following U.S. Stocks are among the “Most Active” Stocks in the course of recent trading session, Wednesday: Citigroup Inc (NYSE:C), Alcoa Inc (NYSE:AA), Facebook Inc (NASDAQ:FB), Geron Corporation (NASDAQ:GERN)

• Citigroup Inc (NYSE:C), with shares gained 2.69% is now trading at $52.62. The Stock is active as 12.55M shares changed hands versus its average volume of 19.59M shares.

• Alcoa Inc (NYSE:AA), with shares surged 0.70% is now trading at $13.60. The Stock is active as 10.72M shares changed hands versus its average volume of 21.88M shares.

• Facebook Inc (NASDAQ:FB) with shares enhanced 0.66% is now trading at $78.06. The Stock is active as 9.44M shares changed hands versus its average volume of 27.17M shares.

• Geron Corporation (NASDAQ:GERN), with shares added 3.17% is now trading at $4.23. The Stock is active as 9.04M shares changed hands versus its average volume of 4.02M shares.

Latest NEWS regarding these Stocks are depicted underneath:

Citigroup Inc. (NYSE:C)

Citigroup Inc. (C), declared that it will launch a banking app designed for Apple Watch™ when Apple brings the device to market in the U.S. on April 24, 2015. Among the first banking apps for a wearable device, the Citi Mobile® Lite app will enable Citi U.S. debit and credit card customers to view account balances and recent transactions and to receive real-time notifications of credit card transactions at a glance right on their wrist with Apple Watch or iPhone.

Direct, password-free access to account information on the Apple Watch and iPhone is enabled by Citi Mobile® Snapshot, an opt-in feature Citi introduced in 2014 that enables customers to view information without having to log into their accounts every time. Citi was the first major U.S. bank to offer the feature.

Citigroup Inc., a diversified financial services holding corporation, provides various financial products and services for consumers, corporations, governments, and institutions worldwide.

Alcoa Inc. (NYSE:AA)

Lightweight, high-performance metals leader Alcoa (AA) is declaring another major milestone in its transformation, further building its value-add portfolio for profitable growth. The Corporation has signed a definitive contract to attain RTI International Metals, Inc. (RTI), a global supplier of titanium and specialty metal products and services for the commercial aerospace, defense, energy and medical device markets. Alcoa will purchase RTI in a stock-for-stock transaction with an enterprise value of $1.5 billion.

With RTI, Alcoa will grow its value-add businesses and further strengthen its aerospace portfolio. RTI will expand Alcoa’s range of titanium offerings and add advanced technologies and materials, increasing the Corporation’s position as a leading industrial innovator.

“Innovation and scale are critical to winning in both the titanium and aerospace industries recently, which is why this transaction is such a natural planned fit for both RTI and Alcoa,” said Dawne Hickton, Vice Chair, President and Chief Executive Officer of RTI International Metals. “We are happy to have an contract with Alcoa that delivers immediate value to our shareholders that appropriately reflects the strength of our business. Through this combination of forces, RTI will take its innovative technologies to the next level and deliver even more value-add titanium solutions to meet customer needs. We look forward to ongoing to accelerate RTI’s success as a part of the Alcoa team.”

Under the terms of the contract, Alcoa will attain all outstanding shares of RTI in a stock-for-stock transaction. RTI shareholders will receive 2.8315 Alcoa shares for each RTI share, representing a value of $41 per RTI share based on Alcoa’s closing price on March 6, 2015. The transaction has an enterprise value of $1.5 billion, counting $330 million of RTI cash on hand and up to $517 million in RTI’s convertible notes.

Transaction Benefits:

The attainment will offer Alcoa financial benefits with realized net synergies of about $100 million in 2019, primarily driven by procurement and productivity improvements, leveraging Alcoa’s global shared services and driving profitable growth. Alcoa anticipates RTI to contribute $1.2 billion in proceeds in 2019, up from $794 million generated in 2014, with 65 percent of proceeds supported by contracts over the next five years. RTI is predictable to reach profitability of 25 percent EBITDA margin in 2019, up from 14.5 percent in 2014.

This transaction is predictable to enable Alcoa to capitalize on strong growth in the commercial aerospace sector. Alcoa projects a compounded annual global aerospace market growth rate of 5 to 6 percent through 2019 and sees a current 9-year production order book for commercial jets at 2014 delivery rates.

RTI grows Alcoa’s pro forma 2014 annual aerospace proceeds by 13 percent, up from $5 billion to $5.6 billion. RTI is predictable to raise Alcoa’s 2014 pro forma aerospace proceeds to 37 percent of value-add sales, up from 35 percent. Alcoa’s aerospace business is the largest contributor to Alcoa’s value-add businesses.

Eighty percent of RTI’s proceeds in 2014 were from the aerospace and defense industries, with the balance mainly split between other markets counting energy and medical devices, complementing Alcoa’s growth markets.

Alcoa Inc. produces and manages primary aluminum, fabricated aluminum, and alumina worldwide. The corporation operates through four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. The Alumina segment is involved in mining bauxite, which is then refined into alumina.

Facebook, Inc. (NASDAQ:FB)

Facebook bows to public pressure, and removed The ‘feeling fat’ emoticon. More than 16,770 people signed a petition, to remove it.

On Tuesday, A chubby-cheeked smiley face with a double chin from “feeling fat” is replaced with “feeling stuffed”.

The petition said that “fat is not a feeling. Fat is a natural part of our bodies, no matter their weight. And all bodies deserve to be respected and cared for.”

“We’ve heard from our community that listing ‘feeling fat’ as an option for status updates could reinforce negative body image, particularly for people struggling with eating disorders. So we’re going to remove ‘feeling fat’ from the list of options,” a Facebook spokesperson said in a statement. “We’ll continue to listen to feedback as we think about ways to help people express themselves on Facebook.”

People can show others how they feel on the social network by posting a status with an emoji, illustrating different emotions including feeling fabulous, proud, lonely and even old.

But with more images, photos, ads and video flooding these websites, social media businesses are also recognizing the impact they can have on a person’s self-esteem and body image.

Facebook, Inc. operates as a social networking corporation worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.

Geron Corporation (NASDAQ:GERN)

Formerly on March 3, Geron Corporation (GERN), stated financial results for the fourth quarter and year ended December 31, 2014 and recent events.

Recent Corporation Events:

On October 31, 2014, the U.S. Food and Drug Administration (“FDA”) removed the full clinical hold on the corporation`s investigational new drug application for imetelstat. In addition, the FDA stated that the corporation`s projected clinical development plan for imetelstat that is focused on high-risk myeloid malignancies, such as myelofibrosis (“MF”), is acceptable.

On November 13, 2014, the corporation reached the Partnership Contract with Janssen to develop and commercialize imetelstat, the corporation`s telomerase inhibitor product candidate, worldwide for all indications in oncology, counting hematologic myeloid malignancies, and all other human therapeutics uses. Under the terms of the Partnership Contract, the corporation received an upfront payment of $35 million and is eligible to receive additional payments up to a potential total of $900 million for the achievement of development, regulatory and commercial milestones, in addition to royalties on worldwide net sales. Certain regulatory, development, manufacturing and promotional activities will be managed through a joint governance structure, with Janssen responsible for operational implementation of these activities.

Geron Corporation, a clinical stage biopharmaceutical corporation, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The corporation was founded in 1990 and is based in Menlo Park, California.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.